mRNA Vaccines Against SARS‐CoV‐2 Variants Delivered by Lipid Nanoparticles Based on Novel Ionizable Lipids

SARS‐CoV‐2 variants are now still challenging all the approved vaccines, including mRNA vaccines. There is an urgent need to develop new generation mRNA vaccines with more powerful efficacy and better safety against SARS‐CoV‐2 variants. In this study, a new set of ionizable lipids named 4N4T are con...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Advanced functional materials Ročník 32; číslo 39; s. 2204692 - n/a
Hlavní autori:	Chen, Kepan, Fan, Na, Huang, Hai, Jiang, Xin, Qin, Shugang, Xiao, Wen, Zheng, Qian, Zhang, Yupei, Duan, Xing, Qin, Zeyi, Liu, Yongmei, Zeng, Jun, Wei, Yuquan, Song, Xiangrong
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Germany Wiley Subscription Services, Inc 01.09.2022 John Wiley and Sons Inc
Predmet:	Antibodies ionizable lipids lipid nanoparticles Lipids Lymphocytes Materials science mRNA delivery mRNA vaccines Nanoparticles Neutralizing Safety SARS‐CoV‐2 variants Severe acute respiratory syndrome coronavirus 2 Vaccines mRNA vaccines SARS‐CoV‐2 variants ionizable lipids lipid nanoparticles mRNA delivery
ISSN:	1616-301X, 1616-3028
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!